Peter Sankey

Statistics

Publications

Citations

450

H-Index

Active since

2020

Affiliations

University Hospitals Plymouth NHS Trust(Current)

University of Glasgow

University College London

Institute of Cancer Research

Royal Marsden NHS Foundation Trust

Peter Sankey is an author at University Hospitals Plymouth NHS Trust specializing in oncology, medicine, and metastatic castration-resistant prostate cancer.

ORCID

Publications per year

2020–2024

Publications

Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters

Jack London, Elnara Fazio‐Eynullayeva, Matvey B. Palchuk et al. · JCO Clinical Cancer Informatics · 2020 · 331 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial

Pasquale Rescigno, Núria Porta, Laura Finneran et al. · European Journal of Cancer · 2024 · 20 citations · Full text

Medicine, Oncology, Pharmacology +12

Immune checkpoint inhibitor induced large vessel vasculitis

Daisy Henderson, Gelareh Eslamian, Daniel Poon et al. · BMJ Case Reports · 2020 · 19 citations · Full text

Medicine, Immunology, Oncology +17

1–4 of 4